ERBB2 and breast cancer: Additionally, hormone receptor-positive MCF-7 breast cancer cells overexpressing HER2 had higher rates of apoptosis with a combination treatment of Herceptin and the STAT3 inhibitor Stattic, compared to either treatment alone [70].